An International Journal of Otorhinolaryngology Clinics

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  15 (2023)
Volume  14 (2022)
Volume  13 (2021)
Volume  12 (2020)
Volume  11 (2019)
Volume  10 (2018)
Volume  9 (2017)
Volume  8 (2016)
Volume  7 (2015)
Volume  6 (2014)
Volume  5 (2013)
Volume  4 (2012)
Volume  3 (2011)
Volume  2 (2010)
Volume  1 (2009)
Related articles

VOLUME 13 , ISSUE 3 ( September-December, 2021 ) > List of Articles

CASE REPORT

Recurrent Laryngeal Papillomatosis: A Laser CO2 Surgery and Bevacizumab Intralesional Injection as Adjuvant Therapy

Cosimo Galletti, Galletti Bruno, Francesco Ciodaro, Francesco Galletti

Keywords : Airway obstruction, Bevacizumab, HPV, Laryngology, Laser, Oncology, Surgery

Citation Information : Galletti C, Bruno G, Ciodaro F, Galletti F. Recurrent Laryngeal Papillomatosis: A Laser CO2 Surgery and Bevacizumab Intralesional Injection as Adjuvant Therapy. Int J Otorhinolaryngol Clin 2021; 13 (3):126-128.

DOI: 10.5005/jp-journals-10003-1386

License: CC BY-NC 4.0

Published Online: 21-04-2022

Copyright Statement:  Copyright © 2021; The Author(s).


Abstract

We present a case of recurrent respiratory papillomatosis (RRP) transformed in a lobular intraepithelial neoplasia LIN 2 vocal fold lesion treated with a microdirect laryngoscope with 10,600-nm laser CO2, in addition, adjuvant therapy is performed which consists of an intralesional bevacizumab injection on surgical site. Adjuvant therapy involves a cycle of four intralesional bevacizumab injections. The RRP is characterized as a long-life condition of the respiratory epithelium caused by the human papilloma virus (HPV), HPV 6 and 11 genotypes in most of all cases. Airway obstruction or voice correlated symptoms are the most common way of presentation, which can be variated from a low–mild form to severe which can represent, in rare cases, a situation that requires prompt treatment. This study aims to evaluate the efficacy and safety of the use of intralesional bevacizumab as adjuvant therapy in the treatment of RRP.

HTML PDF Share
  1. Ballestas SA, Shelly S, Soriano RM, et al. Trends in recurrent Respiratory Papillomatosis Treatment. Acta Otorrinolaringol Esp (Engl Ed) 2021;72(2):109–120. English, Spanish. DOI: 10.1016/j.otorri.2019.11.001. Epub 2020.
  2. Derkay CS, Bluher AE. Update on Recurrent Respiratory Papillomatosis. Otolaryngol Clin North Am 2019;52(4):669–679. DOI: 10.1016/j.otc.2019.03.011. Epub 2019.
  3. Carifi M, Napolitano D, Morandi M, et al. Recurrent Respiratory Papillomatosis: Current and Future Perspectives. Ther Clin Risk Manag 2015;11:731–738. DOI: 10.2147/TCRM.S81825.
  4. Sakakura A, Yamamoto Y, Takasaki T, et al. Recurrent Laryngeal Papillomatosis Developing Into Laryngeal Carcinoma with Human Papilloma Virus (HPV) Type 18: A Case Report. J Laryngol Otol 1996;110(1):75–77. DOI: 10.1017/s0022215100132773.
  5. Ivancic R, Iqbal H, deSilva B, et al. Current and Future Management of Recurrent Respiratory Papillomatosis. Laryngoscope Investig Otolaryngol 2018 14;3(1):22–34. DOI: 10.1002/lio2.132.
  6. Robbins KT, Woodson GE. Current Concepts in the Management of Laryngeal Papillomatosis. Head Neck Surg 1984;6(4):861–866. DOI: 10.1002/hed.2890060410.
  7. Avelino MA, Zaiden TC, Gomes RO. Surgical Treatment and Adjuvant Therapies of Recurrent Respiratory Papillomatosis. Braz J Otorhinolaryngol 2013;79(5):636–642. English, Portuguese. DOI: 10.5935/1808-8694.20130114.
  8. Louw L, Claassen A. HPV-Induced Recurrent Laryngeal Papillomatosis: Rationale for Adjuvant Fatty Acid Therapy. Asia Pac J Clin Nutr 2008;17(2):187–193. PMID: 18586635.
  9. Fernandez-Bussy S, Labarca G, Vial MR, et al. Recurrent Respiratory Papillomatosis and Bevacizumab Treatment. Am J Respir Crit Care Med 2018;197(4):539–541. DOI: 10.1164/rccm.201702-0279LE.
  10. Hermann JS, Pontes P, Weckx LL, et al. Laryngeal Sequelaeof Recurrent Respiratory Papillomatosis Surgery in Children. Rev Assoc Med Bras (1992) 2012;58(2):204–208. PMID: 22569615.
  11. Gazia F, Galletti B, Freni F, et al. Use of Intralesional Cidofovir in the Recurrent Respiratory Papillomatosis: A Review of the Literature. Eur Rev Med Pharmacol Sci 2020;24(2):956–962. DOI: 10.26355/eurrev_202001_20081.
  12. Wierzbicka M, Jackowska J, Bartochowska A, et al. Effectiveness of Cidofovir Intralesional Treatment in Recurrent Respiratory Papillomatosis. Eur Arch Otorhinolaryngol 2011;268(9):1305–1311. DOI: 10.1007/s00405-011-1599-6. Epub 2011.
  13. Naiman AN, Ayari S, Nicollas R, et al. Intermediate-term and Long-Term Results After Treatment by Cidofovir and Excision in Juvenile Laryngeal Papillomatosis. Ann Otol Rhinol Laryngol 2006;115(9): 667–672. DOI: 10.1177/000348940611500903.
  14. Graupp M, Gugatschka M, Kiesler K, et al. Experience of 11 Years Use of Cidofovir in Recurrent Respiratory Papillomatosis. Eur Arch Otorhinolaryngol 2013;270(2):641–646. DOI: 10.1007/s00405-012-2221-2. Epub 2012. Erratum in: Eur Arch Otorhinolaryngol 2013;270(10)2785. PMID: 23070260.
  15. Pudszuhn A, Welzel C, Bloching M, et al. Intralesional Cidofovir Application in Recurrent Laryngeal Papillomatosis. Eur Arch Otorhinolaryngol 2007;264(1):63–70. DOI: 10.1007/s00405-006-0151-6. Epub 2006.
  16. Zeitels SM, Barbu AM, Landau-Zemer T, et al. Local Injection of Bevacizumab (Avastin) and Angiolytic KTP Laser Treatment of Recurrent Respiratory Papillomatosis of the Vocal Folds: A Prospective Study. Ann Otol Rhinol Laryngol 2011;120(10):627–634. DOI: 10.1177/000348941112001001.
  17. Goyal A, Kapoor D, Saha R. Systemic and Intralesional Bevacizumab in Juvenile Onset Recurrent Respiratory Papillomatosis: A Report of Two Cases. Indian J Otolaryngol Head Neck Surg 2021:1–4. DOI: 10.1007/s12070-021-02814-3.
  18. Rogers DJ, Ojha S, Maurer R, et al. Use of Adjuvant Intralesional Bevacizumab for Aggressive Respiratory Papillomatosis in Children. JAMA Otolaryngol Head Neck Surg 2013;139(5):496–501. DOI:10.1001/jamaoto.2013.1810.
  19. Maturo S, Hartnick CJ. Use of 532-nm Pulsed Potassium Titanyl Phosphate Laser and Adjuvant Intralesional Bevacizumab for Aggressive Respiratory Papillomatosis in Children: Initial Experience. Arch Otolaryngol Head Neck Surg 2010;136(6):561–565. DOI: 10.1001/archoto.2010.81.
  20. Kupfer RA, Çadalli Tatar E, Barry JO, et al. Anatomic Derkay Score Is Associated with Voice Handicap in Laryngeal Papillomatosis in Adults. Otolaryngol Head Neck Surg 2016;154(4):689–692. DOI: 10.1177/0194599816628871. Epub 2016.
  21. Loizou C, Laurell G, Lindquist D, et al. Voice and Quality of Life in Patients with Recurrent Respiratory Papillomatosis in a Northern Sweden Cohort. Acta Otolaryngol 2014;134(4):401–406. DOI: 10.3109/00016489.2013.867457. Epub 2014.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.